Potential Activity of Kynurenine Pathway Modulators for Multiple Sclerosis Targeted Therapeutics

被引：0
|
作者：
Sundaram, G. [1 ,2 ]
Lim, C. K. [1 ]
Brew, B. J. [2 ]
Guillemin, G. J. [1 ,2 ]
机构：
[1] Univ New S Wales, Dept Pharmacol & Physiol, Sch Med Sci, Sydney, NSW 2052, Australia
[2] St Vincents Hosp, St Vincents Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：535 / 535
页数：1
相关论文
共 50 条
  • [1] Laquinimod as a regulator of Kynurenine Pathway in Multiple Sclerosis
    Lovelace, Michael
    Sardesai, Varda
    Varney, Bianca
    Guillemin, Gilles J.
    Brew, Bruce J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP27 - NP27
  • [2] Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
    Lim, Chai K.
    Brew, Bruce J.
    Sundaram, Gayathri
    Guillemin, Gilles J.
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2010, 3 : 157 - 167
  • [3] Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
    Wen Zhu
    Kiersten Dykstra
    Lili Zhang
    Zongqi Xia
    Current Treatment Options in Neurology, 2021, 23
  • [4] Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
    Zhu, Wen
    Dykstra, Kiersten
    Zhang, Lili
    Xia, Zongqi
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2021, 23 (11)
  • [5] Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review
    Fathi, Mobina
    Vakili, Kimia
    Yaghoobpoor, Shirin
    Tavasol, Arian
    Jazi, Kimia
    Mohamadkhani, Ashraf
    Klegeris, Andis
    McElhinney, Alyssa
    Mafi, Zahedeh
    Hajiesmaeili, Mohammadreza
    Sayehmiri, Fatemeh
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Current evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
    Lovelace, Michael D.
    Varney, Bianca
    Sundaram, Gayathri
    Franco, Nunzio F.
    Ng, Mei Li
    Pai, Saparna
    Lim, Chai K.
    Guillemin, Gilles J.
    Brew, Bruce J.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [7] Kynurenine Pathway Metabolites as Modulators of Glutamatergic Neurotransmission
    Schwarcz, R.
    Sathyasaikumar, K. V.
    Tararina, M.
    Wu, H. -Q.
    Bortz, D. M.
    Bruno, J. P.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 55 - 55
  • [8] Kynurenine metabolism in multiple sclerosis
    Hartai, Z
    Klivenyi, P
    Janaky, T
    Penke, B
    Dux, L
    Vecsei, L
    ACTA NEUROLOGICA SCANDINAVICA, 2005, 112 (02): : 93 - 96
  • [9] Correction to: Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
    Wen Zhu
    Kiersten Dykstra
    Lili Zhang
    Zongqi Xia
    Current Treatment Options in Neurology, 2021, 23
  • [10] Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
    Lim, Chai K.
    Bilgin, Ayse
    Lovejoy, David B.
    Tan, Vanessa
    Bustamante, Sonia
    Taylor, Bruce V.
    Bessede, Alban
    Brew, Bruce J.
    Guillemin, Gilles J.
    SCIENTIFIC REPORTS, 2017, 7
12345